Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Salbutamol for Oxygenation in COPD During One-lung Ventilation
NCT05914285Active, not recruiting
- Sponsor
- Yonsei University
- Start
- Apr 2023
- Primary completion
- Jun 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of salbutamol in chronic obstructive pulmonary disease (COPD) and hypoxemia (2 arms), sponsored by Yonsei University. Primary endpoint: PaO2 to FiO2 ratio. Started Apr 2023; status: active, not recruiting.
02
Drugs
salbutamol
03
Conditions
chronic obstructive pulmonary disease (COPD)hypoxemia
Beyond the preview
Go deeper on NCT05914285.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05914285.